Shingrix In Recipients of Allogeneic Transplants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Shingrix In Recipients of Allogeneic Transplants — Stella

Home/Bone Marrow Transplant/

View on ClinicalTrials.gov

Recruiting

Back to Bone Marrow Transplant trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Colorado Hospital, Aurora, Colorado

Key details

Phase

Safety & dosing

Sponsor

University of Colorado, Denver

Collaborators

GlaxoSmithKline

Enrollment target

~55 participants

Started

October 2023

Primary completion

January 2028

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 79 Years

Last updated February 2026